Biomarkers Help Identify CHF Patients Needing Med Titration

Share this content:
Biomarkers Help Identify CHF Patients Needing Med Titration
Biomarkers Help Identify CHF Patients Needing Med Titration

THURSDAY, Jan. 25, 2018 (HealthDay News) -- Using biomarkers to identify heart failure patients for up-titration of medications may improve mortality and hospitalization rates, according to a study published in the Jan. 30 issue of the Journal of the American College of Cardiology.

Wouter Ouwerkerk, Ph.D., from the University of Amsterdam, and colleagues compared clinical outcomes of 2,516 patients with worsening heart failure participating in the BIOSTAT-CHF (BIOlogy Study to Tailored Treatment in Chronic Heart Failure) based upon three theoretical treatment scenarios: scenario A, in which all patients are up-titrated to >50 percent of recommended doses; scenario B, in which patients are up-titrated according to a biomarker-based treatment selection; and scenario C, in which no patient is up-titrated to >50 percent of recommended doses.

The researchers found that for 1,802 patients with available biomarker data, estimated death or hospitalization rates were 16, 16, and 26 percent, respectively, in the angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker (ARB) up-titration scenarios A, B, and C. In the three scenarios, rates with beta-blocker and mineralocorticoid receptor antagonist (MRA) up-titration were 23, 19, and 24 percent and 12, 11, and 24 percent, respectively. At 24 months, an estimated 9.8, 1.3, and 12.3 events per 100 treated patients could be prevented by ACE inhibitor/ARB, beta-blocker, and MRA therapy, respectively, if up-titration was successful in all patients. Events prevented were similar if up-titration treatment decision was based on a biomarker-based treatment selection model.

"Up-titrating patients with heart failure based on biomarker values might have resulted in fewer deaths or hospitalizations compared with a hypothetical scenario in which all patients were successfully up-titrated," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »